Title Alternative Drug interaction (33. Combination with antimicrobial agents)
FullText URL 127_151.pdf
Author Tasaka, Ken| Shiraishi, Naoko| Kitamura, Yoshihisa| Sendo, Toshiaki|
Publication Title 岡山医学会雑誌
Published Date 2015-08-03
Volume volume127
Issue issue2
Start Page 151
End Page 154
ISSN 0030-1558
Related Url isVersionOf https://doi.org/10.4044/joma.127.151
language Japanese
Copyright Holders Copyright (c) 2015 岡山医学会
File Version publisher
DOI 10.4044/joma.127.151
NAID 130005096260
Author Zamami, Yoshito| Koyama, Toshihiro| Aiba, Tetsuya| Amano, Manabu| Ando, Tetsuaki| Kurata, Naomi| Nawa, Hideki| Nakura, Hironori| Kitamura, Yoshihisa| Sendo, Toshiaki|
Published Date 2014
Publication Title 静脈経腸栄養
Volume volume29
Issue issue4
Content Type Journal Article
Title Alternative Drug interaction (32. Drug interaction in novel oral anticoagulants)
FullText URL 127_59.pdf
Author Ida, Hiromi| Kitamura, Yoshihisa| Sendo, Toshiaki|
Publication Title 岡山医学会雑誌
Published Date 2015-04-01
Volume volume127
Issue issue1
Start Page 59
End Page 61
ISSN 0030-1558
Related Url http://www.okayama-u.ac.jp/user/oma/
language Japanese
Copyright Holders Copyright (c) 2015 岡山医学会
File Version publisher
DOI 10.4044/joma.127.59
NAID 130005068338
Title Alternative Drug interaction (31. drug interaction in hormonal breast cancer therapy)
FullText URL 126_245.pdf
Author Masaoka, Yasuyuki| Kitamura, Yoshihisa| Sendo, Toshiaki|
Publication Title 岡山医学会雑誌
Published Date 2014-12-01
Volume volume126
Issue issue3
Start Page 245
End Page 248
ISSN 0030-1558
language Japanese
Copyright Holders Copyright (c) 2014 岡山医学会
File Version publisher
DOI 10.4044/joma.126.245
NAID 130004903247
JaLCDOI 10.18926/AMO/52893
FullText URL 68_5_255.pdf
Author Esumi, Satoru| Kawasaki, Yoichi| Gomita, Yutaka| Kitamura, Yoshihisa| Sendo, Toshiaki|
Abstract Motivation incorporates several psychological aspects that produce reward-related and learning behaviors. Although reward-related behavior is reported to be mediated by the dopaminergic reward pathway, the involvement of dopaminergic systems in motivated behavior has not been fully clarified. Several experimental methodologies for motivational behavior have been reported, but pharmacological characteristics seem to vary among these methodologies. In this review, we attempt to summarize three main concepts:(1) the relationship of dopamine neuron physiology with motivated behavior, (2) the pharmacological characteristics of the runway intracranial self-stimulation model, and (3) the behavioral distinction of disparate motivated behaviors.
Keywords motivation reward dopamine operant behavior intracranial self-stimulation
Amo Type Review
Publication Title Acta Medica Okayama
Published Date 2014-10
Volume volume68
Issue issue5
Publisher Okayama University Medical School
Start Page 255
End Page 262
ISSN 0386-300X
NCID AA00508441
Content Type Journal Article
language English
Copyright Holders CopyrightⒸ 2014 by Okayama University Medical School
File Version publisher
Refereed True
PubMed ID 25338481
Web of Science KeyUT 000343269300001
Title Alternative Drug interaction (30. combination with therapeutic drugs for chronic pain)
FullText URL 126_159.pdf
Author Ogawa, Atsushi| Kitamura, Yoshihisa| Sendo, Toshiaki|
Publication Title 岡山医学会雑誌
Published Date 2014-08-01
Volume volume126
Issue issue2
Start Page 159
End Page 163
ISSN 0030-1558
language Japanese
Copyright Holders Copyright (c) 2014 岡山医学会
File Version publisher
DOI 10.4044/joma.126.159
NAID 130004685269
Title Alternative Drug interaction (29. drug interaction of steroids)
FullText URL 126_59.pdf
Author Hayashi, Youko| Nawa, Hideki| Kitamura, Yoshihisa| Sendo, Toshiaki|
Publication Title 岡山医学会雑誌
Published Date 2014-04-01
Volume volume126
Issue issue1
Start Page 59
End Page 63
ISSN 0030-1558
Related Url http://www.okayama-u.ac.jp/user/oma/
language Japanese
Copyright Holders Copyright (c) 2014 岡山医学会
File Version publisher
DOI 10.4044/joma.126.59
Author Haruta, Yusuke| Kawasaki, Yoichi| Kitamura, Yoshihisa| Sendo, Toshiaki|
Published Date 2013-12-02
Publication Title 岡山医学会雑誌
Volume volume125
Issue issue3
Content Type Journal Article
JaLCDOI 10.18926/AMO/51868
FullText URL 67_5_319.pdf
Author Murakawa, Kiminaka| Sato, Tomoaki| Maeda, Yoshinobu| Kitamura, Yoshihisa| Tanimoto, Mitsune| Sendo, Toshiaki|
Abstract Graft-versus-host disease (GVHD) is a major concern in transplantation patients. Gut GVHD is accompanied by diarrhea, abdominal pain, and/or melena. Although oral treatment with corticosteroids (CSs) is effective in treating gut GVHD, it can cause adverse reactions that affect the entire body. Topical administration of CSs can be effective in treating diseases in which lesions are limited locally, because adverse reactions can then be alleviated. In this study, we examine and discuss an enteric-coated beclomethasone dipropionate (BDP) capsule (BDP-EC) formulated at Okayama University Hospital. The BDP-EC did not dissolve in solution 1 (pH1.2), and began disintegrating in solution 2 (pH6.8) after 5min, with a mean dissolution rate at 15min of 85%. We then used the capsule to treat a patient who developed gut GVHD after allogeneic hematopoietic stem cell transplantation. Clinically, the frequency of diarrhea decreased after BDP-EC administration. In addition, we were able to decrease the prednisolone equivalent dose. Symptoms associated with adverse reactions to BDP were not observed during the hospitalization period. These findings suggest that the administration of BDP-EC in the early stages of gut GVHD may allow a reduction in the initial doses of systemic CSs.
Keywords beclomethasone intestinal graft-versus-host disease enteric-coated capsule in-hospital formulation
Amo Type Case Report
Publication Title Acta Medica Okayama
Published Date 2013-10
Volume volume67
Issue issue5
Publisher Okayama University Medical School
Start Page 319
End Page 324
ISSN 0386-300X
NCID AA00508441
Content Type Journal Article
language English
Copyright Holders CopyrightⒸ 2013 by Okayama University Medical School
File Version publisher
Refereed True
PubMed ID 24145732
Web of Science KeyUT 000325836100006
Author Kurata, Yasuko| Fujiwara, Satoko| Kajizono, Makoto| Aoyagi, Megumu| Kitamura, Yoshihisa| Sendo, Toshiaki|
Published Date 2013-08-01
Publication Title 岡山医学会雑誌
Volume volume125
Issue issue2
Content Type Journal Article
Author Makita, Takashi| Kitamura, Yoshihisa| Sendo, Toshiaki|
Published Date 2013-04-01
Publication Title 岡山医学会雑誌
Volume volume125
Issue issue1
Content Type Journal Article
JaLCDOI 10.18926/AMO/40129
FullText URL 64_4_219.pdf
Author Doi, Maho| Miyazaki, Ikuko| Nagamachi, Tomoko| Shinomiya, Kazuaki| Matsunaga, Hisashi| Sendo, Toshiaki| Kawasaki, Hiromu| Asanuma, Masato| Gomita, Yutaka| Kitamura, Yoshihisa|
Abstract We examined the influence of chronic adrenocorticotropic hormone (ACTH) treatment on the number of Ki-67-positive cells in the dentate gyrus of the hippocampus in rats. ACTH treatment for 14 days decreased the number of such cells. The administration of imipramine or lithium alone for 14 days had no effect in saline-treated rats. The effect of ACTH was blocked by the administration of imipramine. Furthermore, the coadministration of imipramine and lithium for 14 days significantly increased the number of Ki-67-positive cells in both the saline and ACTH-treated rats. The coadministration of imipramine and lithium normalized the cell proliferation in the dentate gyrus of the hippocampus in rats treated with ACTH.
Keywords ACTH imipramine lithium proliferation Ki-67
Amo Type Original Article
Publication Title Acta Medica Okayama
Published Date 2010-08
Volume volume64
Issue issue4
Publisher Okayama University Medical School
Start Page 219
End Page 223
ISSN 0386-300X
NCID AA00508441
Content Type Journal Article
language English
Copyright Holders Okayama University Medical School
File Version publisher
Refereed True
PubMed ID 20802538
Web of Science KeyUT 000281384400002
FullText URL fulltext.pdf
Author Kitamura, Yoshihisa| Akiyama, Kozue| Kitagawa, Kouhei| Shibata, Kazuhiko| Kawasaki, Hiromu| Suemaru, Katsuya| Araki, Hiroaki| Sendo, Toshiaki| Gomita, Yutaka|
Keywords Imipramine Carbamazepine ACTH 5-HT2A receptor Forced swim test Wet-dog shakes Treatment–resistant
Note Published with permission from the copyright holder.
This is a author's copy,as published in Pharmacology Biochemistry and Behavior , 2008, volume 89, issue 3, pp235-240.
|
Published Date 2008-05-20
Publication Title Pharmacology Biochemistry and Behavior
Volume volume89
Issue issue3
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
File Version author
DOI 10.1016/j.pbb.2007.12.015
Web of Science KeyUT 000255311600001
Author Hobara, Narumi| Goda, Mitsuhiro| Yoshida, Namika| Takatori, Shingo| Kitamura, Yoshihisa| Mio, Mitsunobu| Kawasaki, Hiromu|
Published Date 2008-05-28
Publication Title Neuroscience
Volume volume150
Issue issue3
Content Type Journal Article
JaLCDOI 10.18926/AMO/32879
FullText URL fulltext.pdf
Author Umeda, Yuichi| Amano, Manabu| Suemaru, Katsuya| Yamaguchi, Takumi| Kitamura, Yoshihisa| Gomita, Yutaka| Kawasaki, Hiromu| Araki, Hiroaki|
Abstract

Hyperactivity of the hypothalamic-pituitary-adrenal (HPA) axis induces hyperglycemia and serotonin (5-HT)2A receptor supersensitivity. In the present study, to investigate the effect of hyperglycemia on the function of 5-HT2A receptors, we compared the 5-HT2A receptor-mediated wet-dog shake responses in rats treated with adrenocorticotropic hormone (ACTH), dexamethasone and streptozotocin. ACTH (100 μg/rat per day, s.c.), dexamethasone (1 mg/kg per day, s.c.) and streptozotocin (60 mg/kg, i.p.) produced significant hyperglycemia at 14 days after the start of these treatments, and the hyperglycemia was most pronounced in the streptozotocin-treated rats. The wet-dog shake responses induced by (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI), a 5-HT2A receptor agonist, were significantly enhanced at 14 days after repeated treatment with ACTH and dexamethasone. However, streptozotocin-induced diabetes had no effect on the wet-dog shake responses. The results of the present study suggest that hyperglycemia is not strongly associated with the enhanced susceptibility of 5-HT2A receptors under the condition of hyperactivity of the HPA axis.

Keywords hyperglycemia ACTH dexamethasone streptozotocin 5-HT2A receptor
Amo Type Original Article
Publication Title Acta Medica Okayama
Published Date 2007-12
Volume volume61
Issue issue6
Publisher Okayama University Medical School
Start Page 311
End Page 317
ISSN 0386-300X
NCID AA00508441
Content Type Journal Article
language English
File Version publisher
Refereed True
PubMed ID 18183075
Web of Science KeyUT 000251943800001
JaLCDOI 10.18926/AMO/32092
FullText URL fulltext.pdf
Author Kitamura, Yoshihisa| Araki, Hiroaki| Nagatani, Tadashi| Takao, Katsuyuki| Shibata, Kazuhiko| Gomita, Yutaka|
Abstract

We studied the influence of imipramine on the duration of immobility in chronic forced-swim-stressed rats. Both single and chronic administration of imipramine potently shortened immobility in naive rats during forced-swim testing. However, chronic, 14-day forced-swim stress testing blocked the immobility-decreasing effect induced by a single administration of imipramine. When imipramine was administered for 14 days concurrently with forced-swim stress testing, immobility was shortened significantly. From the viewpoint of imipramine's effect, these findings suggest that chronic forced-swim stress testing in rats may be an effective animal model for depression.

Keywords stress depression imipramine forced-swim test animal model
Amo Type Article
Publication Title Acta Medica Okayama
Published Date 2004-12
Volume volume58
Issue issue6
Publisher Okayama University Medical School
Start Page 271
End Page 274
ISSN 0386-300X
NCID AA00508441
Content Type Journal Article
language English
File Version publisher
Refereed True
PubMed ID 15762295
Web of Science KeyUT 000225959100003
JaLCDOI 10.18926/AMO/30940
FullText URL fulltext.pdf
Author Sagara, Hidenori| Kitamura, Yoshihisa| Esumi, Satoru| Sendo, Toshiaki| Araki, Hiroaki| Gomita, Yutaka|
Abstract

It is well known that priming stimulation promotes the motivational effects of intracranial self-stimulation(ICSS) behavior. An experimental methodology using the runway method could separately study the reward and motivational effects of ICSS behavior. In the present study, we examined the motivational effect of nicotine as measured by the runway method using priming stimulation of ICSS behavior. Electrodes were implanted chronically into the medial forebrain bundle (MFB) in rats. A lever for stimulation of the MFB was set on the opposite side of the start box in the apparatus, and rats were trained to get a reward stimulation (50-200 microA, 0.2 ms, 60 Hz) of MFB when the goal lever was pressed. After the rats were trained to press the lever, a priming stimulation of the MFB was performed. After receiving the priming stimulation, rats were placed at the start box of the runway apparatus, and the running time duration until the goal lever was pressed was measured. Subcutaneous injection of nicotine at a dose of 0.2mg/kg produced an increase in running speed to obtain the reward stimulation, and priming stimulation facilitated the motivational effect to obtain the electrical brain stimulation reward in the rats. These results suggest that nicotine significantly enhanced the motivational effect on ICSS behavior as determined using the runway method. The runway method using priming stimulation of ICSS behavior may become the new experimental methodology with which to measure the motivational effect of some drugs.

Keywords intracranial self-stimulation runway nicotine priming stimulation motivational effect
Amo Type Original Article
Publication Title Acta Medica Okayama
Published Date 2008-08
Volume volume62
Issue issue4
Publisher Okayama University Medical School
Start Page 227
End Page 233
ISSN 0386-300X
NCID AA00508441
Content Type Journal Article
language English
File Version publisher
Refereed True
PubMed ID 18766205
Web of Science KeyUT 000258680900002
JaLCDOI 10.18926/14809
FullText URL 74_051_056.pdf
Author 北村 佳久| 三宅 悟| 横山 紀子| 川上 英治| 荒木 博陽| 柴田 和彦| 五味田 裕| Mitsunobu, Fumihiro| Tanizaki, Yoshiro|
Abstract 新規ロイコトリエン(LT)受容体桔抗薬であるモンテルカスト服用によるテオフイリン服用患者の処方動向,臨床検査値ならびに患者の服用に対する意識について検討を行った。 その結果,テオフイリン服用患者177名の内,51%がLT受容体抵抗薬を併用しており,併用率はモンテルカストが最も多く,プランルカスとザフィルルカストの順であった。また,プランルカストからモンテルカストに変更された症例が多かった。臨床検査値はモンテルカスト服用により血中好酸球数の減少作用が認められた。肝機能検査値(AST・ALT・ALP)は影響しなかった。テオフイリン服用量はモンテルカスト併用服用により減量され,それに伴い血中濃度も低下した。しかしながら,血中濃度/投与量比は影響しなかったことより,モンテルカストはテオフイリンクリアランスに影響しないと考えられる。モンテルカストヘの変更により,患者の服薬コンプライアンスは良好に維持され,自覚する副作用の発現は認められ なかった。以上の結果,テオフイリン服用患者へのモンテルカスト併用投与は良好な服薬コンプライアンスを維持させ,さらにテオフイリンの体内動態に影響を及ぼすことなく,テオフイリンの投与量を減少させ,患者のQOLの向上につながると考えられる。
Keywords モンテルカスト テオフイリン 服薬コンプライアンス 血中濃度
Publication Title 岡大三朝医療センター研究報告
Published Date 2004-02-01
Volume volume74
Start Page 51
End Page 56
ISSN 1348-1258
language Japanese
File Version publisher
NAID 120002308033
Author Sagara, Hidenori| Kitamura, Yoshihisa| Sendo, Toshiaki| Gomita, Yutaka|
Published Date 2007-05-01
Publication Title 岡山医学会雑誌
Volume volume119
Issue issue1
Content Type Journal Article
Author Shinomiya, Kazuaki| Kitamura, Yoshihisa| Ueshima, Satoshi| Satoh, Tomoaki| Sendo, Toshiaki|
Published Date 2008-05-01
Publication Title 岡山医学会雑誌
Volume volume120
Issue issue1
Content Type Journal Article